# Wigen Biomedicine Technology (Shanghai)

Source: https://onco.cc/companies/wigen-biomedicine-technology-shanghai/  
OnCo record `wigen-biomedicine-technology-shanghai` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Wigen Biomedicine Technology (Shanghai) is a China-based biotechnology company running 2 late-stage cancer trials of WJB001.

## Summary

Wigen Biomedicine Technology (Shanghai), based in Shanghai, China, is a biotechnology company. Wigen Biomedicine develops innovative anti-tumour drugs using small-molecule covalent/allosteric, PROTAC and drug-conjugate technology platforms. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing WJB001. The largest, NCT05773820 (A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumours), plans to enrol 210 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Tags: ctgov-sponsor
- HQ: Shanghai
- Type: biotech
- Website: https://www.wigenbio.com

## Sources

- Official website: https://www.wigenbio.com
- ClinicalTrials.gov: trials led by Wigen Biomedicine Technology (Shanghai): https://clinicaltrials.gov/search?lead=Wigen%20Biomedicine%20Technology%20(Shanghai)%20Co.%2C%20Ltd.

## Connected records

- technologies: [PROTACs & molecular glues (targeted protein degradation)](https://onco.cc/technologies/protac-degrader/)
- drugs: [WJB001](https://onco.cc/drugs/wjb001/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)
- trials: [A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors](https://onco.cc/trials/nct06953323/), [A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors](https://onco.cc/trials/nct05773820/)

---
JSON: https://onco.cc/api/v1/entities/wigen-biomedicine-technology-shanghai.json